Friday, December 24, 2021 11:39:34 AM
Don't believe institutional money would be spent on an OTC stock under $0.10, but I agree with the rest. Also, it would shout that the BP believes in RGBP's product enough to make a $250M bet... which is huge, and would lend a ton of credibility to the company within the investment community... I appreciate your posts... Merry Christmas to you and all longs...!!! Remember Christ is the reason for the season...(-:
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
